Cargando…
Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer
Breast cancer is a heterogeneous disease whose subtypes represent different histological origins, prognoses, and therapeutic sensitivity. But there remains a strong need for more specific biomarkers and broader alternatives for personalized treatment. Our study classified breast cancer samples from...
Autores principales: | Gao, Shengnan, Wu, Xinjie, Lou, Xiaoying, Cui, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630632/ https://www.ncbi.nlm.nih.gov/pubmed/36338982 http://dx.doi.org/10.3389/fgene.2022.960567 |
Ejemplares similares
-
Identification of the Pyroptosis-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2021) -
Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma
por: Lin, Jianwei, et al.
Publicado: (2021) -
Identification of the Transcription Co-Factor–Related Gene Signature and Risk Score Model for Osteosarcoma
por: Jin, Zhijian, et al.
Publicado: (2022) -
Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019) -
Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021)